Graph Therapeutics

Seed
graphtx.com AI & Machine Learning Vienna, Austria
Total Funding $5M
Latest Round $5M Seed
Last Announced Jun 22, 2026
Investors Undisclosed
Decision Makers 5 Verified

About Graph Therapeutics

Graph Therapeutics is a precision immunology biotech company that uses AI, multi-omics analysis, and patient cell data for treatments.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry AI & Machine Learning
Funding Stage Seed
Global Headquarters Vienna, Austria
Tracked Since Oct 2, 2026

Web & Domain Identity

Official Website graphtx.com
Domain Registered Date Feb 19, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $5,000,000 · Seed

    Dealroom

  2. Milestone

    Website domain registered

    graphtx.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Graph Therapeutics.

Funding History

1 Round
Seed · Jun 22, 2026
$5,000,000 Dealroom

Founders & Leadership

6

Berend Snijder

Founder

Work email & phone locked Unlock →

Bojan Vilagos

Founder

Work email & phone locked Unlock →

Christophe Boudesco

Founder

Work email & phone locked Unlock →

Gregory Vladimer

Founder

Work email & phone locked Unlock →

Robert Sehlke

Founder

Work email & phone locked Unlock →

Yannic Severin

Founder

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded AI & Machine Learning Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts